Yondelis



Indications and Reactions:

Role Indications Reactions
Primary
Ovarian Cancer 42.0%
Premedication 12.4%
Product Used For Unknown Indication 11.9%
Hypertension 4.4%
Infection 4.4%
Ovarian Cancer Recurrent 4.4%
Ovarian Cancer Metastatic 3.1%
Depression 2.7%
Adenocarcinoma 1.8%
Hypothyroidism 1.8%
Prophylaxis Of Nausea And Vomiting 1.8%
Sarcoma 1.8%
Antiemetic Supportive Care 1.3%
Blood Calcium Decreased 0.9%
Breast Cancer 0.9%
Chemotherapy 0.9%
Diabetes Mellitus 0.9%
Hypercholesterolaemia 0.9%
Leiomyosarcoma 0.9%
Neoplasm Malignant 0.9%
Pancytopenia 19.0%
Urinary Tract Infection 12.1%
Renal Failure Acute 10.3%
Vomiting 10.3%
Phlebitis 6.9%
Respiratory Failure 5.2%
Cognitive Disorder 3.4%
Diarrhoea 3.4%
Febrile Neutropenia 3.4%
Neutrophil Count Decreased 3.4%
Palpitations 3.4%
Pyrexia 3.4%
Rhabdomyolysis 3.4%
Acute Myocardial Infarction 1.7%
Anaemia 1.7%
Aspartate Aminotransferase Increased 1.7%
Asthenia 1.7%
Atrial Fibrillation 1.7%
Cardiac Failure 1.7%
Cardiac Failure Congestive 1.7%
Secondary
Ovarian Cancer 29.9%
Premedication 15.9%
Hypertension 9.2%
Product Used For Unknown Indication 5.9%
Chemotherapy 5.4%
Sarcoma 4.3%
Depression 3.8%
Liposarcoma 3.5%
Hypothyroidism 3.0%
Adenocarcinoma 2.2%
Blood Calcium Decreased 2.2%
Diabetes Mellitus 2.2%
Hypercholesterolaemia 2.2%
Oedema Due To Cardiac Disease 2.2%
Platelet Aggregation Inhibition 2.2%
Prophylaxis Of Nausea And Vomiting 1.9%
Ovarian Cancer Recurrent 1.3%
Leiomyosarcoma 1.1%
Ovarian Cancer Metastatic 1.1%
Antiemetic Supportive Care 0.8%
Phlebitis 18.8%
Pancytopenia 8.2%
Vomiting 8.2%
Blood Creatine Phosphokinase Increased 7.1%
Hypoalbuminaemia 7.1%
Neutropenia 7.1%
Urinary Tract Infection 7.1%
Renal Failure Acute 5.9%
Acute Myocardial Infarction 4.7%
Cardiac Failure 4.7%
Malaise 3.5%
Rhabdomyolysis 3.5%
Cognitive Disorder 2.4%
Diarrhoea 2.4%
Neutrophil Count Decreased 2.4%
Palpitations 2.4%
Aspartate Aminotransferase Increased 1.2%
Asthenia 1.2%
Cardiac Failure Congestive 1.2%
Febrile Neutropenia 1.2%
Concomitant
Product Used For Unknown Indication 36.8%
Ovarian Cancer 31.6%
Synovial Sarcoma 21.1%
Breast Cancer Metastatic 10.5%
Fanconi Syndrome 25.0%
Lung Infection 25.0%
Sepsis 25.0%
Tachycardia 25.0%